Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients

OncoImmunology

Volumn 1, Issue 8, 2012, Pages 1305-1312

  de Boniface, Jana ^a,b   Mao, Yumeng ^a   Schmidt Mende, Jan ^a   Kiessling, Rolf ^a   Poschke, Isabel ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Arginase; Cancer; Immunosuppression; Mammary carcinoma; Myeloid cells

Indexed keywords

ARGINASE 1; CD11B ANTIGEN; CD14 ANTIGEN;

ADULT; AGED; ARTICLE; BONE MARROW CELL; BREAST CANCER; CANCER GRADING; CANCER INFILTRATION; CANCER STAGING; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME SPECIFICITY; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MASTECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SENTINEL LYMPH NODE BIOPSY; TISSUE DISTRIBUTION; TUMOR VOLUME; UPREGULATION;

EID: 84879424156     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.21678     Document Type: Article

References (26)

1. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336:1-17; PMID:9806879.
2. Jacobsen LC, Theilgaard-Mönch K, Christensen EI, Borregaard N. Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils. Blood 2007; 109:3084-7; PMID:17119118.
3. Munder M, Mollinedo F, Calafat J, Canchado J, Gil-Lamaignere C, Fuentes JM, et al. Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 2005; 105:2549-56; PMID:15546957; http://dx.doi.org/10.1182/blood-2004-07-2521.
4. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-74; PMID:19197294; http://dx.doi.org/10.1038/nri2506.
5. Gallina G, Dolcetti L, Serafini P, De Santo C, Marigo I, Colombo MP, et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 2006; 116:2777-90; PMID:17016559; http://dx.doi.org/10.1172/JCI28828.
6. Haile LA, Gamrekelashvili J, Manns MP, Korangy F, Greten TF. CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice. J Immunol 2010; 185:203-10; PMID:20525890; http://dx.doi.org/10.4049/jimmunol.0903573.
7. Mantovani A, Sica A, Allavena P, Garlanda C, Locati M. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum Immunol 2009; 70:325-30; PMID:19236898; http://dx.doi.org/10.1016/j.humimm.2009.02.008.
8. Grabon W, Mielczarek-Puta M, Chrzanowska A, Baranczyk-Kuzma A. L-arginine as a factor increasing arginase significance in diagnosis of primary and metastatic colorectal cancer. Clin Biochem 2009; 42:353-7; PMID:19101531; http://dx.doi.org/10.1016/j.clinbiochem.2008.11.018.
9. Polat MF, Taysi S, Polat S, Böyük A, Bakan E. Elevated serum arginase activity levels in patients with breast cancer. Surg Today 2003; 33:655-61; PMID:12928840; http://dx.doi.org/10.1007/s00595-002-2563-2.
10. Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R, et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009; 69:1553-60; PMID:19201693; http://dx.doi.org/10.1158/0008-5472.CAN-08-1921.
11. Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, Zabaleta J, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 2005; 65:3044-8; PMID:15833831.
12. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002; 169:2756-61; PMID:12193750.
13. Boniface JD, Poschke I, Mao Y, Kiessling R. Tumordependent down-regulation of the χ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function. Int J Cancer 2012; 131:129-39; PMID:21823123; http://dx.doi.org/10.1002/ijc.26355.
14. Poschke I, De Boniface J, Mao Y, Kiessling R. Tumorinduced changes in the phenotype of blood-derived and tumor-associated T cells of early stage breast cancer patients. Int J Cancer 2012; 131:1611-20; PMID:22190148; http://dx.doi.org/10.1002/ijc.27410.
15. Raychaudhuri B, Rayman P, Ireland J, Ko J, Rini B, Borden EC, et al. Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neuro Oncol 2011; 13:591-9; PMID:21636707; http://dx.doi.org/10.1093/neuonc/nor042.
16. Bryk JA, Popovic PJ, Zenati MS, Munera V, Pribis JP, Ochoa JB. Nature of myeloid cells expressing arginase 1 in peripheral blood after trauma. J Trauma 2010; 68:843-52; PMID:19996805.
17. Makarenkova VP, Bansal V, Matta BM, Perez LA, Ochoa JB. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol 2006; 176:2085-94; PMID:16455964.
18. Ochoa JB, Bernard AC, Mistry SK, Morris SM Jr., Figert PL, Maley ME, et al. Trauma increases extrahepatic arginase activity. Surgery 2000; 127:419-26; PMID:10776433; http://dx.doi.org/10.1067/msy.2000.104745.
19. Brys L, Beschin A, Raes G, Ghassabeh GH, Noël W, Brandt J, et al. Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection. J Immunol 2005; 174:6095-104; PMID:15879104.
20. Zea AH, Culotta KS, Ali J, Mason C, Park HJ, Zabaleta J, et al. Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment. J Infect Dis 2006; 194:1385-93; PMID:17054067; http://dx.doi.org/10.1086/508200.
21. Davis JS, Anstey NM. Is plasma arginine concentration decreased in patients with sepsis? A systematic review and meta-analysis. Crit Care Med 2011; 39:380-5; PMID:21150584; http://dx.doi.org/10.1097/CCM.0b013e3181ffd9f7.
22. Popovic PJ, Zeh HJ 3rd, Ochoa JB. Arginine and immunity. J Nutr 2007; 137(Suppl 2):1681S-6S; PMID:17513447.
23. Moskovitz DN, Kim YI. Does perioperative immunonutrition reduce postoperative complications in patients with gastrointestinal cancer undergoing operations?. Nutr Rev 2004; 62:443-7; PMID:15622717; http://dx.doi.org/10.1111/j.1753-4887.2004.tb00016.x.
24. De Santo C, Salio M, Masri SH, Lee LY, Dong T, Speak AO, et al. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloidderived suppressor cells in mice and humans. J Clin Invest 2008; 118:4036-48; PMID:19033672; http://dx.doi.org/10.1172/JCI36264.
25. Serafini P, Meckel K, Kelso M, Noonan K, Califano J, Koch W, et al. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. J Exp Med 2006; 203:2691-702; PMID:17101732; http://dx.doi.org/10.1084/jem.20061104.
26. Boniface JD, Poschke I, Mao Y, Kiessling R. Tumordependent down-regulation of the χ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function. Int J Cancer 2012; 131:129-39; PMID:21823123; http://dx.doi.org/10.1002/ijc.26355.